A Severe Complication of Sepsis: Purpura Fulminans
Purpura fulminans (PF), is a fatal disease which develops acutely and is characterised by skin necrosis, microvascular clotting, and purpuric lesions generally seen during or after an infection. Early diagnosis and treatment of PF is important for the prevention of longterm sequelae and to reduce mortality. It is a disease with an acute onset, characterised by microvascular clotting, leading to purpuric lesions and skin necrosis that can have a fatal outcome. Disseminated intravascular coagulation (DIC) is often seen, and as in the current patient, this can progress to septic shock. The case is here presented of a patient who developed purpura fulminans while under follow up for intra-abdominal sepsis, and the intensive care follow-up period is discussed..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi - 27(2022), 3, Seite 504-508 |
Sprache: |
Englisch ; Türkisch |
---|
Beteiligte Personen: |
Onurcan BALIK [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Disseminated intravascular coagulation |
---|
doi: |
10.5578/flora.20229714 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ020206623 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ020206623 | ||
003 | DE-627 | ||
005 | 20230501183940.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.5578/flora.20229714 |2 doi | |
035 | |a (DE-627)DOAJ020206623 | ||
035 | |a (DE-599)DOAJ5494913639e54299b51f2d3a25d18aa1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng |a tur | ||
050 | 0 | |a RC109-216 | |
050 | 0 | |a QR1-502 | |
100 | 0 | |a Onurcan BALIK |e verfasserin |4 aut | |
245 | 1 | 2 | |a A Severe Complication of Sepsis: Purpura Fulminans |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Purpura fulminans (PF), is a fatal disease which develops acutely and is characterised by skin necrosis, microvascular clotting, and purpuric lesions generally seen during or after an infection. Early diagnosis and treatment of PF is important for the prevention of longterm sequelae and to reduce mortality. It is a disease with an acute onset, characterised by microvascular clotting, leading to purpuric lesions and skin necrosis that can have a fatal outcome. Disseminated intravascular coagulation (DIC) is often seen, and as in the current patient, this can progress to septic shock. The case is here presented of a patient who developed purpura fulminans while under follow up for intra-abdominal sepsis, and the intensive care follow-up period is discussed. | ||
650 | 4 | |a purpura fulminans | |
650 | 4 | |a disseminated intravascular coagulation | |
650 | 4 | |a sepsis | |
653 | 0 | |a Infectious and parasitic diseases | |
653 | 0 | |a Microbiology | |
700 | 0 | |a Pınar KARABACAK |e verfasserin |4 aut | |
700 | 0 | |a Mustafa Kemal YILDIRIM |e verfasserin |4 aut | |
700 | 0 | |a Onur KAYA |e verfasserin |4 aut | |
700 | 0 | |a Filiz ALKAYA SOLMAZ |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi |d Bilimsel Tip Yayinevi, 2018 |g 27(2022), 3, Seite 504-508 |w (DE-627)DOAJ000080411 |x 1300932X |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2022 |g number:3 |g pages:504-508 |
856 | 4 | 0 | |u https://doi.org/10.5578/flora.20229714 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/5494913639e54299b51f2d3a25d18aa1 |z kostenfrei |
856 | 4 | 0 | |u http://floradergisi.org/managete/fu_folder/2022-03/504-508%20Onurcan%20Balik.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1300-932X |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1308-5115 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 27 |j 2022 |e 3 |h 504-508 |